 14. Any clinically significant medical condition, other than DMD that in the opinion of the Investigator may increase the risk of participating in the study or interfere with the interpretation of safety or efficacy evaluations e.g., concomitant illness, severe reflux, psychiatric condition or behavioural disorder. 